Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424722 · ClinicalTrials.gov registry record · NA
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 2,258
- Enrollment target
NCT01424722: Clinical Trial NA study, sponsored by Abbott Medical Devices.
NCT01424722 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 2,258 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01424722, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 2,258 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized, multicenter, pivotal Investigational Device Exemption (IDE) study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in St Jude Medical ICD systems.
Interventions
- DEVICE Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,258 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-06 |
| Phase | NA |
Why NCT01424722 stopped before completion
NCT01424722 is an interventional study that assigns participants to a tested intervention. Its 2,258 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 1 intervention - of which Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices is the first listed.
NCT01424722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01424722 about?
NCT01424722 is a clinical study titled "ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients". This is a prospective, non-randomized, multicenter, pivotal Investigational Device Exemption (IDE) study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in St Jude Medical ICD systems.
What is the current status of trial NCT01424722?
This trial is currently terminated. It is a NA study. The enrollment target is 2,258 participants. The study started on 2011-08. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01424722?
The interventions under investigation include: Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices (DEVICE).
Who is sponsoring clinical trial NCT01424722?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01424722's enrollment target sits among peer trials
2,258 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia